معرفی
Robin S. Bon is Associate Professor of Chemical Biology in the School of Medicine at the University of Leeds, affiliated with the Leeds Institute of Cardiovascular and Metabolic Medicine and the Astbury Centre for Structural Molecular Biology. His research spans chemical biology, structural pharmacology, and early-stage drug discovery, with lab spaces in both the LIGHT laboratories and the School of Chemistry.
His educational background includes a PhD in Chemistry from Vrije Universiteit Amsterdam and a BSc in Chemistry from HU Utrecht. He is a Member of the Royal Society of Chemistry and a Fellow of the Higher Education Academy, recognized for his contributions to teaching and research supervision.
Dr. Bon's research focuses on the structural and functional mechanisms of TRPC1/4/5 cation channels and the mitochondrial chaperonin HSPD1 as a therapeutic target in glioblastoma. He employs advanced techniques including photoaffinity labelling, mass spectrometry, and cryo-electron microscopy. He also develops innovative LALDI-MS methods for biomolecule analysis. His work supports drug discovery collaborations, including with CalTIC GmbH.
The absence of listed publications prevents trend analysis, but his research consistently integrates chemical tool development with disease-targeted structural biology.
- Fellow of the Higher Education Academy
Dr. Bon has supervised numerous students and leads postgraduate research opportunities in drug discovery and chemical biology. He has developed and delivered multiple advanced courses in organic synthesis, protein labelling, and ion channel pharmacology. His research is supported by interdisciplinary grants and institutional collaborations, particularly within the Astbury Centre. He currently serves as Deputy Head of Department (Research & Innovation).
His research group operates across the LIGHT laboratories (for mammalian cell culture and biochemistry), the School of Chemistry (organic and analytical chemistry), and the Astbury Biostructure Laboratory (cryo-EM), reflecting a highly collaborative and multidisciplinary approach.
